• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » depression

Articles Tagged with ''depression''

Expert Q&A

Ketamine Use and Misuse

April 1, 2024
Keith A. Trujillo, PhD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

CATR_QA2_KeithTrujillo_headshot.jpegKeith A. Trujillo, PhD.  

Emeritus Professor of Psychology, California State University, San Marcos, CA.

Dr. Trujillo has no financial relationships with companies related to this material.

Ketamine and esketamine represent some of the most powerful rapid-acting agents in our armamentarium of treatments for depression. However, ketamine is also an addictive substance, and there is emerging evidence that the widespread use of ketamine may be causing more patient harms than we were previously aware of. Here, Dr. Trujillo discusses how to use ketamine safely in clinical practice.


Read More
Clinical Update

A Personalized Approach to Antidepressant Augmentation

April 1, 2024
Deepti Anbarasan, MD and David Liebers, MD
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Deepti Anbarasan, MD. Associate Professor, Psychiatry and Neurology, New York University, New York, NY.

David Liebers, MD. Psychiatry resident at NYU Langone Department of Psychiatry. 

The authors have no financial relationships with companies related to this material.

The best augmentation strategy varies by patient. Learn which features help personalize the plan.


Read More
Research Update

Intermittent Theta-Burst Stimulation for Depression and Suicidality

March 1, 2024
Kate J. Travis, MD
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Kate Travis, MD. Dr. Travis has no financial relationships with companies related to this material.

Although intermittent theta-burst stimulation demonstrates efficacy in depression treatment, we look into how it addresses suicidality?


Read More
shutterstock_2428554093.jpg

Hypnotic Depression Throwback

February 22, 2024
Chris Aiken, MD and Kellie Newsome, PMHNP

Here's a Throwback Thursday episode originally cast in March of 2021, where we're going to look at the question of whether adding a z hypnotic improves antidepressant response. And stay tuned to the very end where I'm going to update it with new research. We all know that when you sleep better, you feel better.


Read More
shutterstock_2425592969.jpg

Throwback Benzos

February 15, 2024
Chris Aiken, MD and Kellie Newsome, PMHNP

The release of the fast-acting antidepressant Auvelity got us thinking about an older strategy to speed up antidepressants: benzodiazepines. So we're bringing you this Thursday throwback, do benzodiazepines treat depression? Benzos and sleep meds rarely earn a mention in textbooks on depression these days, but that has not always been the case. (Part 1 of a 2 part series)


Read More
shutterstock_137226314.jpg

Auvelity: 4 Controversies

February 12, 2024
Chris Aiken, MD and Kellie Newsome, PMHNP

Auvelity, a new rapid acting medication for depression, is a branded combination of two generic drugs. We look at its side effects, addictive potential, and whether you can just use the generic components.


Read More
shutterstock_571617067.jpg

Auvelity A Fast Acting Antidepressant

February 5, 2024
Chris Aiken, MD and Kellie Newsome, PMHNP

Auvelity, a new rapid acting medication for depression, is a branded combination of two generic drugs. We look at how it works and the clinical trials, including new data in treatment resistant depression



Read More
Expert Q&A

Tolerability of Vortioxetine for Pediatric Anxiety and Depressive Disorders

January 1, 2024
Kathryn Martin, MD, MPH
From The Carlat Child Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Kathryn Martin, MD, MPH. Dr. Martin discloses that she owns shares in a variety of pharmaceutical companies. Relevant financial relationships listed for the author have been mitigated.

Vortioxetine has to be reasonably tolerated in children and teens, with manageable side effects, to have any chance of inclusion into treatment for anxiety or depression. This research update gives you the latest on whether vortioxetine might be a viable approach even before we have good efficacy studies. 


Read More
Research Update

Large Longitudinal Study Links Mild Depression and Dementia

January 1, 2024
Kathryn Kieran, MSN, PMHNP-BC
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Kathryn Kieran, MSN, PMHNP-BC. Ms. ­Kieran has no financial relationships with ­companies related to this material.

This study showed a dose-response relationship between depression severity and cognitive decline.


Read More
QA photo_T Schwartz_.jpg
Expert Q&A

How to Choose an Antidepressant

January 1, 2024
Thomas Schwartz, MD
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

QA photo_T Schwartz_.jpgThomas Schwartz, MD.

Professor and Chair, Department of Psychiatry and Behavioral Sciences, Alan and Marlene Norton College of Medicine, SUNY Upstate Medical University, Syracuse, NY.

Dr. Schwartz has no financial relationships with companies related to this material.

Thomas Schwartz clarifies how to choose an antidepressant and finds a place for underutilized agents like trazodone and levomilnacipran (Fetzima).


Read More
Previous 1 2 3 4 5 6 7 8 9 10 … 19 20 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • MFB8e_SpiralCover.png

    Medication Fact Book for Psychiatric Practice, Eighth Edition (2026)

    Updated 2026 prescriber's guide.
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2716137939.jpg
    Child Psychiatry

    Living Without Illusions: Psychological Survival in a World of Persistent Hatred

    Today’s episode is one we’ve been sitting with for a long time. We’re talking about how to survive psychologically in a world where hatred is persistent, not abstract,...

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.